BSPM OTC
Biostar Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$5M
-16.4% ▼
5Y CAGR: -11.0%
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$5M
-15.6% ▼
5Y CAGR: -2.4%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$134K
+108.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | $809K | $5M | -$25M | -$6M |
| Depreciation & Amort. | $2M | $3M | $3M | $2M | $1M |
| Stock-Based Comp. | $822K | $757K | $2M | $0 | $0 |
| Change in Working Capital | $6M | $2M | -$6M | $5M | $7M |
| Other Non-Cash Items | $9M | $1M | $4M | $4M | -$227K |
| Operating Cash Flow | -$4M | $9M | $3M | $6M | $5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$33K | -$982K | -$3M | -$59K | $0 |
| Acquisitions (Net) | -$824K | -$4M | -$5M | -$8M | -$6M |
| Investment Purchases | $0 | $0 | $0 | -$804K | $0 |
| Investment Sales | $0 | $0 | $0 | $804K | $0 |
| Other Investing | -$16M | $646K | -$1M | $804K | -$6M |
| Investing Cash Flow | -$17M | -$4M | -$9M | -$7M | -$6M |
| — Financing Activities — | |||||
| Net Debt Issuance | $6M | -$5M | $3M | -$161K | -$278K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$2M | $0 | $0 | $0 |
| Financing Cash Flow | $6M | -$6M | $7M | -$161K | $1M |
| Net Change in Cash | -$15M | -$2M | $2M | -$2M | $134K |
| Cash End of Period | $2M | $80K | $2M | $39K | $173K |
| Free Cash Flow | -$4M | $8M | $441K | $6M | $5M |